glp 1 studies 2025 Beyond GLP-1: the next wave of weight-loss medication innovation Issue 42: GLP-1 RA Drug

The use of lorcaserin is associated with an additional annual weight loss of about 3.23.6 kg as well as improvements in metabolic parameters including blood pressure (systolic, 0.61 mmHg

Semaglutide shelf life after reconstitution or first use depends on the formulation

During the IPGTT, the hypoglycemic effect of t D-G1A was greater

The anticipated launch of emerging therapies in the Prader-Willi syndrome landscape is expected to reshape the competitive dynamics, posing both challenges and opportunities for Solenos VYKAT XR

By blocking K+ channels, GLP-1 depolarizes the cell and causes calcium influx, and thus causes exocytosis of insulin from the beta-cell